Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Breckenridge

Showing results (11-20 of 140) with videos related to

Pageof 14
Sort By:
American Journal of Hypertension|January 1, 1991
Angiotensin converting enzyme inhibitors and quality of lifeA Breckenridge
British Medical Journal (Clinical Research Ed.)|July 13, 1985
Treating mild hypertensionA Breckenridge
BMJ (Clinical Research Ed.)|October 28, 1989
Risks and benefits of prophylactic antimalarial drugsA Breckenridge
Clinical Pharmacology and Therapeutics|January 30, 2007
The future of drug safetyA Breckenridge
Pharmacology & Therapeutics|January 1, 1987
Enzyme induction in humans. Clinical aspects--an overviewA Breckenridge
British Journal of Clinical Pharmacology|July 1, 1995
Science, medicine and clinical pharmacology. The Lilly Lecture 1994A Breckenridge
BMJ (Clinical Research Ed.)|February 11, 1995
Clinical pharmacology and therapeuticsA Breckenridge
British Medical Journal (Clinical Research Ed.)|February 20, 1982
Jogger's blockadeA Breckenridge
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 1, 1986
Ketanserin--a new antihypertensive agentA Breckenridge
British Medical Journal (Clinical Research Ed.)|February 27, 1988
Angiotensin converting enzyme inhibitorsA Breckenridge
Pageof 14

Showing results (11-20 of 140) with videos related to

Sort By:
Pageof 14
American Journal of Hypertension|January 1, 1991
Angiotensin converting enzyme inhibitors and quality of lifeA Breckenridge
British Medical Journal (Clinical Research Ed.)|July 13, 1985
Treating mild hypertensionA Breckenridge
BMJ (Clinical Research Ed.)|October 28, 1989
Risks and benefits of prophylactic antimalarial drugsA Breckenridge
Clinical Pharmacology and Therapeutics|January 30, 2007
The future of drug safetyA Breckenridge
Pharmacology & Therapeutics|January 1, 1987
Enzyme induction in humans. Clinical aspects--an overviewA Breckenridge
British Journal of Clinical Pharmacology|July 1, 1995
Science, medicine and clinical pharmacology. The Lilly Lecture 1994A Breckenridge
BMJ (Clinical Research Ed.)|February 11, 1995
Clinical pharmacology and therapeuticsA Breckenridge
British Medical Journal (Clinical Research Ed.)|February 20, 1982
Jogger's blockadeA Breckenridge
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 1, 1986
Ketanserin--a new antihypertensive agentA Breckenridge
British Medical Journal (Clinical Research Ed.)|February 27, 1988
Angiotensin converting enzyme inhibitorsA Breckenridge
Pageof 14